Their program has VACCINES written ALL OVER IT.

About Inovio
https://www.inovio.com/about

Inovio is bringing IMMUNO-INGENUITY™ to life and is reshaping the future of treating and preventing cancer and infectious diseases.

Inovio's technology platform is capable of activating antigen-specific immune responses. With demonstrated efficacy in a Phase 2b trial, robust and targeted immune responses, a favorable safety profile, and a robust pipeline of product candidates across multiple disease states, the evidence to date is clear—Inovio is realizing the true promise of immunotherapy.

Executive Team
J. Joseph Kim, Ph.D.
President, Chief Executive Officer, Director

As President, CEO and Director of Inovio, Dr. Kim is a trailblazer who has successfully led the company since 2009 with ingenuity and strategic practicality to become a thriving late-stage biotech that is deeply focused on developing next-generation immunotherapies to improve patient lives.

An immunologist by training, Dr. Kim holds a unique perspective in understanding the complexities of healthcare’s greatest unsolved challenges. His drive to improve and enhance patient lives is woven into the daily fabric of company culture.

Dr. Kim is also a global thought leader that has published more than 100 peer-reviewed scientific papers, holds numerous patents and sits on several editorial boards and review panels including most recently recognized as a Young Global Leader by the World Economic Forum and a Health Innovators Fellow at The Aspen Institute. He previously co-founded VGX Pharmaceuticals, an immunotherapeutic company that he led for nine years until combining VGX with Inovio Biomedical in 2009 to form Inovio Pharmaceuticals.

Dr. Kim earned a B.S. degree in Chemical Engineering and Economics from the Massachusetts Institute of Technology, a Ph.D. in Biochemical Engineering/Immunology from the University Pennsylvania, and a Master of Business Administration degree in Finance from the Wharton School.

---

David B. Weiner, Ph.D.
Executive Vice President, Director, Vaccine Center, The Wistar Institute

David Weiner is Executive Vice President of The Wistar Institute, Director of its Vaccine Center, and the W. W. Smith Charitable Trust Endowed Professorship in Cancer Research. The Wistar Institute is the nation’s first independent biomedical research institute, NCI-designated Cancer Center, and an international leader in cancer, immunology, and infectious disease research. Previously, Dr. Weiner was Professor, Department of Pathology & Laboratory Medicine at the University of Pennsylvania and Chair of the Gene Therapy and Vaccine Program at the University’s Perelman School of Medicine and co-leader of the Tumor Virology Program of the Abramson Cancer Center at Penn.

Dr. Weiner is a world-renowned leader in immunology as well as gene vaccines and immunotherapy. In scientific circles he is known as the “father of DNA vaccines.” He has more than 350 peer-reviewed publications in scientific journals, including mainstream scientific journals such as Scientific American, and has been designated by the Institute for Scientific Information as one of the top-cited scientists in the world. An inventor of more than 100 issued and pending U.S. patents, Dr. Weiner has received numerous honors, including election as a fellow to the American Association for the Advancement of Science in 2011 and the International Society for Vaccines in 2012. He was the recipient of the NIH Director’s Transformative Research Award and the Vaccine Industry Excellence Award for Best Academic Research Team at the World Vaccine Congress in 2015 and again in 2016. Weiner was honored with the prestigious Hilleman Lectureship in 2015 at the Children’s Hospital of Philadelphia Grand Rounds session and received a Stone Family Award from Abramson Cancer Center for his groundbreaking work on DNA vaccines for cancer immune therapy.

David Weiner holds a Ph.D. in developmental biology from the University of Cincinnati College of Medicine, an M.S. in biology from the University of Cincinnati, and a B.S. in biology from SUNY at Stony Brook in Stony Brook, New York.